A detailed history of Commerce Bank transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Commerce Bank holds 6,789 shares of TGTX stock, worth $241,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,789
Holding current value
$241,824
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$21.31 - $35.09 $144,673 - $238,226
6,789 New
6,789 $204,000
Q2 2021

Aug 09, 2021

SELL
$32.5 - $48.96 $143,910 - $216,794
-4,428 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$25.27 - $54.9 $111,895 - $243,097
4,428 New
4,428 $230,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.17B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Commerce Bank Portfolio

Follow Commerce Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.